VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 103 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $293,725 | -7.9% | 37,900 | -44.1% | 0.00% | -33.3% |
| Q1 2021 | $319,000 | -33.4% | 67,782 | +1.1% | 0.00% | -40.0% |
| Q4 2020 | $479,000 | -5.9% | 67,021 | +40.4% | 0.01% | -28.6% |
| Q3 2020 | $509,000 | -20.5% | 47,730 | -5.9% | 0.01% | -22.2% |
| Q2 2020 | $640,000 | +3.7% | 50,696 | -24.8% | 0.01% | -10.0% |
| Q1 2020 | $617,000 | -41.2% | 67,397 | -10.4% | 0.01% | +25.0% |
| Q4 2019 | $1,050,000 | -17.2% | 75,260 | +2.1% | 0.01% | -20.0% |
| Q3 2019 | $1,268,000 | -39.6% | 73,684 | -4.4% | 0.01% | -37.5% |
| Q2 2019 | $2,098,000 | +39.4% | 77,092 | -2.0% | 0.02% | +45.5% |
| Q1 2019 | $1,505,000 | +112.9% | 78,637 | +4.5% | 0.01% | +120.0% |
| Q4 2018 | $707,000 | -34.9% | 75,243 | +31.1% | 0.01% | -28.6% |
| Q3 2018 | $1,086,000 | +18.6% | 57,399 | +22.4% | 0.01% | +16.7% |
| Q2 2018 | $916,000 | – | 46,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |